Cargando…
Majoon Chobchini attenuates arthritis disease severity and RANKL-mediated osteoclastogenesis in rheumatoid arthritis
Majoon Chobchini, a polyherbal Unani compound, has been used holistically in India to treat rheumatoid arthritis. However, the potential mechanism underlying the antiarthritic efficacy of Majoon Chobchini has not been elucidated so far. This study was aimed to explore the underlying molecular mechan...
Autores principales: | Samarpita, Snigdha, Doss, Hari Madhuri, Ganesan, Ramamoorthi, Rasool, Mahaboobkhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446481/ https://www.ncbi.nlm.nih.gov/pubmed/34549015 http://dx.doi.org/10.1007/s13205-021-02985-4 |
Ejemplares similares
-
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
por: Kim, Jeong Yeon, et al.
Publicado: (2012) -
Poisoning by Majoon or Májum
por: Cullen, P.
Publicado: (1868) -
Excavatolide B Attenuates Rheumatoid Arthritis through the Inhibition of Osteoclastogenesis
por: Lin, Yen-You, et al.
Publicado: (2017) -
Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug
por: Samarpita, Snigdha, et al.
Publicado: (2020) -
The molecular mechanism of osteoclastogenesis in rheumatoid arthritis
por: Udagawa, Nobuyuki, et al.
Publicado: (2002)